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Introduction
TRAPS is an autosomal dominant disease due to mutations
in the TNFRSF1A gene.
Objectives
to analyze the clinical features of TRAPS and genotype/
phenotype correlations of TRAPS patients enrolled in
the Eurofever/Eurotraps registry.
Methods
The Eurofever Project (agreement n 2007332, EAHC) is
aimed to build a common web-based registry for all
Autoinflammatory diseases in collaboration with the
Eurotraps Project (FP7, HEALTH-F2-2008-200923). A
web-based registry collecting demographic and clinical
information on Autoinflammatory diseases is available
in the member area of the PRINTO web-site.
Results
158 TRAPS pts were enrolled from November 2009 to
June 2012. analyzed. The majority of pts were adults
(105, 67%). The median age at disease onset and at disease
diagnosis were 4.1 (range 0.2-63 years) and 25.9 (0-77)
years, respectively. The median delay of diagnosis was
10.3 years, with a rate of delay 10 times higher in adult
patients. Patients were enrolled by 18 centers in 11 coun-
tries, with 18 different countries of origin. 145 (91%) were
European Caucasians, 4 Arabs, 3 black Africans, 2 Asiatics,
2 Ashkenazi Jewish, 2 had a mixed origin. 58 pts (36.7%)
carried high-penetrant mutations (T50M or involving
cysteine residues), 30 pts (19%) other missense mutations
previously associated to TRAPS phenotype. Low-penetrant
or hypomorphic variants, such as R92Q and P46L, were
found in 53 and 5 pts, respectively. 12 pts carried muta-
tions with uncertain association with TRAPS phenotype.
High penetrant mutations were observed in 50/123 (40%)
pts with pediatric onset and in 8/35 pts (22.9%) with an
adult onset (p < 0.001). The prevalence of patients carrying
low-penetrant or hypomorphyc mutations were two time
higher in the adult onset (48%) compared with pediatric
onset (25.2%) (p < 0.001).
Mean duration of fever episodes was 10.6 days with
mean number of 6.6 episodes/year. In one third of the
cohort a mean duration of fever episodes was shorter
than 1 week. The most frequent symptoms accompanying
attacks were fever, limb pain (arthalgia, myalgia), abdom-
inal pain and a variety of skin rashes. The prevalence of a
number of clinical manifestations significantly differ
among the age of onset. Pediatric patients displayed an
increased prevalence of enlarged cervical lymph nodes
abdominal pain and periorbital edema in respect to
patients with an adult onset. Adult onset was characterized
by an higher prevalence of respiratory symptoms (chest
pain, persistent cough), serositis and polyarthritis. The
most common long term complication was amyloidosis,
that was observed in 16 (10%) adult patients. The mean
age at onset of amyloidosis was 43 years (range 20-77).
Patients who developed AA amyloidosis had significantly
longer disease duration than those who have not (39 years
versus 19.4 years; p=0.001).
Conclusion
TRAPS has a wide geographical distribution and can be
observed in different ethnicities. Short episodes (less than
1 week) are observed in 30% of patients. The presentation
of the disease in adulthood significantly differs from that
observed in pediatric age.
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